Envía por correo este artículo 
Tratamiento de conducto en pacientes con terapia de fármacos antirresortivos. Revisión bibliográfica
Resumen
Este artículo revisa la evidencia científica actual sobre las consideraciones del tratamiento endodóntico para pacientes que se someten a terapia farmacológica antirresortiva. Se llevó a cabo una búsqueda sistemática de la literatura en las principales bases de datos PUBMED, SCIELO, SCOPUS, EBSCO y SCIENCE DIRECT. Utilizando criterios rigurosos de inclusión y exclusión. El análisis se centra en temas clave como tratamiento endodóntico, las posibles complicaciones y la osteonecrosis. Los datos extraídos de estudios elegibles revelaron las implicaciones de bisfosfonatos y otros medicamentos antirresortivos en procedimientos endodónticos, particularmente en el tratamiento de conducto radicular. Basado en hallazgos, esta revisión proporciona recomendaciones prácticas para el manejo efectivo de la atención endodóntica en pacientes que reciben terapia antirresortiva.
Palabras clave
Referencias
Mortensen, M., Lawson, W., & Montazem, A. (2007). Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review. The Laryngoscope, 117(1), 30–34. https://doi.org/10.1097/01.mlg.0000240885.64568.9e
Assaf, A. T., Smeets, R., Riecke, B., Weise, E., Gröbe, A., Blessmann, M., Steiner, T., Wikner, J., Friedrich, R. E., Heiland, M., Hoelzle, F., & Gerhards, F. (2013). Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies. Anticancer research, 33(9), 3917–3924.
Khan, A. A., Morrison, A., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., Watts, N. B., Brandi, M. L., Peters, E., Guise, T., Eastell, R., Cheung, A. M., Morin, S. N., Masri, B., Cooper, C., Morgan, S. L., … International Task Force on Osteonecrosis of the Jaw (2015). Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research, 30(1), 3–23. https://doi.org/10.1002/jbmr.2405
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., Lavecchia, C., Zhang, J., Mesenbrink, P., Hodgson, P. K., Abrams, K., Orloff, J. J., Horowitz, Z., Eriksen, E. F & Boonen, S. (2007). Zoledronic acid and clinical fractures and mortality after hip fracture. The New England journal of medicine, 357(18), 1799–1809. https://doi.org/10.1056/NEJMoa074941
Song M. (2019). Dental care for patients taking antiresorptive drugs: a literature review. Restorative dentistry & endodontics, 44(4), e42. https://doi.org/10.5395/rde.2019.44.e42
Ruggiero, S. L., Mehrotra, B., Rosenberg, T. J., & Engroff, S. L. (2004). Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 62(5), 527–534. https://doi.org/10.1016/j.joms.2004.02.004
American Dental Association Council on Scientific Affairs (2006). Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. Journal of the American Dental Association (1939), 137(8), 1144–1150. https://doi.org/10.14219/jada.archive.2006.0355
Sedghizadeh, P. P., Sun, S., Jones, A. C., Sodagar, E., Cherian, P., Chen, C., Junka, A. F., Neighbors, J. D., McKenna, C. E., Russell, R. G. G., & Ebetino, F. H. (2021). Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications. Bone, 147, 115933. https://doi.org/10.1016/j.bone.2021.115933
Lee, E. S., Tsai, M. -C., Lee, J. -X., Wong, C., Cheng, Y. -N., Liu, A. -C., Liang, Y. -F., Fang, C. -Y., Wu, C. -Y., & Lee, I. -T. (2023). Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws. Cancers, 15(22), 5366. https://doi.org/10.3390/cancers15225366
Cotti, E., Mezzena, S., Schirru, E., Ottonello, O., Mura, M., Ideo, F., Susnik, M., & Usai, P. (2018). Healing of Apical Periodontitis in Patients with Inflammatory Bowel Diseases and under Anti-tumor Necrosis Factor Alpha Therapy. Journal of endodontics, 44(12), 1777–1782. https://doi.org/10.1016/j.joen.2018.09.004
Moinzadeh, A. T., Shemesh, H., Neirynck, N. A., Aubert, C., & Wesselink, P. R. (2013). Bisphosphonates and their clinical implications in endodontic therapy. International endodontic journal, 46(5), 391–398. https://doi.org/10.1111/iej.12018
Aminoshariae, A., Kulild, J. C., Mickel, A., & Fouad, A. F. (2017). Association between Systemic Diseases and Endodontic Outcome: A Systematic Review. Journal of endodontics, 43(4), 514–519. https://doi.org/10.1016/j.joen.2016.11.008
Borromeo, G. L., Tsao, C. E., Darby, I. B., & Ebeling, P. R. (2011). A review of the clinical implications of bisphosphonates in dentistry. Australian dental journal, 56(1), 2–9. https://doi.org/10.1111/j.1834-7819.2010.01283.x
Rojas, Carolina, Rivera, Carolina, Villanueva, Julio, & Yanine, Nicolás. (2015). Manejo endodóntico en pacientes con riesgo de osteonecrosis asociada a bifosfonatos: Scoping review. Revista clínica de periodoncia, implantología y rehabilitación oral, 8(2), 176-181. https://dx.doi.org/10.1016/j.piro.2015.04.002
Ruggiero, S. L., Dodson, T. B., Aghaloo, T., Carlson, E. R., Ward, B. B., & Kademani, D. (2022). American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 80(5), 920–943. https://doi.org/10.1016/j.joms.2022.02.008
Lugo Pinto, M., Martínez Peraza, V., & Cuesta Durazno, A. (2024). Tratamiento de conducto como terapia preventiva a la osteonecrosis de los maxilares: reporte de caso clínico. Polo del Conocimiento, 9(8), 3366-3376. doi:https://doi.org/10.23857/pc.v9i8.7886
Gupta, M., & Gupta, N. (2023). Bisphosphonate Related Jaw Osteonecrosis. In StatPearls. StatPearls Publishing.
Fernández-Ávila, D. G., Ávila, V., Muñoz, O., Moreno, I., Ballén, D., Veloza, J., & Gutiérrez, J. M. (2022). Conocimientos y decisiones clínicas de los odontólogos colombianos acerca del riesgo de las osteonecrosis de los maxilares en pacientes que reciben tratamiento para la osteoporosis. Revista de Osteoporosis y Metabolismo Mineral, 14(1), 55-63. https://doi.org/10.4321/S1889-836X2022000100007
Migliorati, C. A., Hsu, C. J., Chopra, S., & Kaltman, S. S. (2008). Dental management of patients with a history of bisphosphonate therapy: clinical dilemma. Journal of the California Dental Association, 36(10), 769–774.
American Association of Endodontists. (2010). AAE position statement: Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws. American Association of Endodontists. https://www.aae.org/specialty/wp-content/uploads/sites/2/2017/07/bisphosonatesstatement.pdf
Kiho, K., Sumitomo, S., Tanaka, M., Hasegawa, T., Sakai, C., Takitani, Y., Yoshida, T., & Kawano, S. (2020). Pulpal Disease Arising from Medication-related Osteonecrosis of the Jaw: A Case Report. Journal of endodontics, 46(8), 1149–1154. https://doi.org/10.1016/j.joen.2020.04.010
Kumar S. K. (2012). Medication nonadherence: a role for the dental professional. Journal of the California Dental Association, 40(8), 663–668.
Rajchenberg, J., & Fernández, D. (2021). Osteonecrosis de los maxilares asociada a bifosfonatos y su relación con la terapéutica endodóntica: una revisión. Acta Odontológica Venezolana, 59(1), 1-13.
Katz, J., & Rotstein, I. (2021). Prevalence of Periapical Lesions in Patients with Osteoporosis. Journal of endodontics, 47(2), 234–238. https://doi.org/10.1016/j.joen.2020.10.019
Segura Egea, J. J., Sánchez Domínguez, B., Montero Miralles, P., Martín González, J., Alonso Ezpeleta, O., & Forner Navarro, L. (2020). Recomendaciones de la Asociación Española de Endodoncia sobre el uso de antibióticos en endodoncia. Asociación Española de Endodoncia (AEDE). http://www.cooecs.es/wp-content/uploads/2020/10/RECOMENDACIONES_AEDE_ANTIBIOTICOS1.pdf
Xu, X., Zheng, X., Lin, F., Yu, Q., Hou, B., Chen, Z., Wei, X., Qiu, L., Wenxia, C., Li, J., Chen, L., Wang, Z., Wu, H., Lu, Z., Zhao, J., Liang, Y., Zhao, J., Pan, Y., Pan, S., Wang, X., … Zhou, X. (2024). Expert consensus on endodontic therapy for patients with systemic conditions. International journal of oral science, 16(1), 45. https://doi.org/10.1038/s41368-024-00312-0
Zamparini, F., Pelliccioni, G. A., Spinelli, A., Gissi, D. B., Gandolfi, M. G., & Prati, C. (2021). Root canal treatment of compromised teeth as alternative treatment for patients receiving bisphosphonates: 60-month results of a prospective clinical study. International endodontic journal, 54(2), 156–171. https://doi.org/10.1111/iej.13405
Hsiao, A., Glickman, G., & He, J. (2009). A retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates. Journal of endodontics, 35(11), 1525–1528. https://doi.org/10.1016/j.joen.2009.07.020
Barker, K., & Rogers, S. (2006). Bisphosphonate-associated Osteonecrosis of the jaws: a guide for the general dental practitioner. Dental update, 33(5), 270–275. https://doi.org/10.12968/denu.2006.33.5.270
Marx, R. E., Sawatari, Y., Fortin, M., & Broumand, V. (2005). Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 63(11), 1567–1575. https://doi.org/10.1016/j.joms.2005.07.010
Sarathy, A. P., Bourgeois, S. L., Jr, & Goodell, G. G. (2005). Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports. Journal of endodontics, 31(10), 759–763. https://doi.org/10.1097/01.don.0000182737.09980.2c
Sigua-Rodriguez, E. A., da Costa Ribeiro, R., de Brito, A. C., Alvarez-Pinzon, N., & de Albergaria-Barbosa, J. R. (2014). Bisphosphonate-related osteonecrosis of the jaw: a review of the literature. International journal of dentistry, 2014, 192320. https://doi.org/10.1155/2014/192320
AlRahabi, M. K., & Ghabbani, H. M. (2018). Clinical impact of bisphosphonates in root canal therapy. Saudi medical journal, 39(3), 232–238. https://doi.org/10.15537/smj.2018.3.20923
Xiong, H., Wei, L., Hu, Y., Zhang, C., & Peng, B. (2010). Effect of alendronate on alveolar bone resorption and angiogenesis in rats with experimental periapical lesions. International endodontic journal, 43(6), 485–491. https://doi.org/10.1111/j.1365-2591.2010.01703.x
Najeeb, S., Siddiqui, F., Khurshid, Z., Zohaib, S., Zafar, M. S., & Ansari, S. A. (2017). Effect of bisphosphonates on root resorption after tooth replantation - a systematic review. Dental traumatology: official publication of International Association for Dental Traumatology, 33(2), 77–83. https://doi.org/10.1111/edt.12316
Favia, G., Pilolli, G. P., & Maiorano, E. (2009). Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy. Bone, 45(3), 406–413. https://doi.org/10.1016/j.bone.2009.05.008
Cousido, M. C., Tomás Carmona, I., García-Caballero, L., Limeres, J., Alvarez, M., & Diz, P. (2010). In vivo substantivity of 0.12% and 0.2% chlorhexidine mouthrinses on salivary bacteria. Clinical oral investigations, 14(4), 397–402. https://doi.org/10.1007/s00784-009-0320-2
Beth-Tasdogan, N. H., Mayer, B., Hussein, H., & Zolk, O. (2017). Interventions for managing medication-related osteonecrosis of the jaw. The Cochrane database of systematic reviews, 10(10), CD012432. https://doi.org/10.1002/14651858.CD012432.pub2
Cordero, Erita, & Aguero, Ignacio. (2022). Osteonecrosis de los Maxilares, Puesta al Día. International journal of odontostomatology, 16(1), 52-59. https://dx.doi.org/10.4067/S0718-381X2022000100052
Bertó, A., Miñana, M., & Miñana, R. (2007). ONJ (Osteonecrosis de los maxilares relacionada con bifosfonatos): Guía para el tratamiento y prevención en endodoncia. Gaceta Dental, 179, 52-58. https://dialnet.unirioja.es/servlet/articulo?codigo=2271639
Nase, J. B., & Suzuki, J. B. (2006). Osteonecrosis of the jaw and oral bisphosphonate treatment. Journal of the American Dental Association (1939), 137(8), 1115–1170. https://doi.org/10.14219/jada.archive.2006.0350
Bamias, A., Kastritis, E., Bamia, C., Moulopoulos, L. A., Melakopoulos, I., Bozas, G., Koutsoukou, V., Gika, D., Anagnostopoulos, A., Papadimitriou, C., Terpos, E., & Dimopoulos, M. A. (2005). Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23(34), 8580–8587. https://doi.org/10.1200/JCO.2005.02.8670
Dominguez, L. J., Di Bella, G., Belvedere, M., & Barbagallo, M. (2011). Physiology of the aging bone and mechanisms of action of bisphosphonates. Biogerontology, 12(5), 397–408. https://doi.org/10.1007/s10522-011-9344-5
Otsuru, M., Fujiki, Y., Soutome, S., Nakamura, N., Miyoshi, T., Naruse, T., Ohnuma, M., Hotokezaka, Y., Rokutanda, S., & Umeda, M. (2024). Risk factors for dental findings of the development of medication-related osteonecrosis of the jaw: Investigation of 3734 teeth in cancer patients receiving high dose antiresorptive agents. Journal of Dental Sciences, 19(1), 203-210. https://doi.org/10.1016/j.jds.2023.04.026
Kyrgidis, A., Arora, A., Lyroudia, K., & Antoniades, K. (2010). Root canal therapy for the prevention of osteonecrosis of the jaws: an evidence-based clinical update. Australian endodontic journal : the journal of the Australian Society of Endodontology Inc, 36(3), 130–133. https://doi.org/10.1111/j.1747-4477.2010.00280.x
Gallego, L., Junquera, L., Pelaz, A., & Díaz-Bobes, C. (2011). Rubber dam clamp trauma during endodontic treatment: a risk factor of bisphosphonate-related osteonecrosis of the jaw?. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons, 69(6), e93–e95. https://doi.org/10.1016/j.joms.2010.06.197
Dereci, Ö., Orhan, E. O., Irmak, Ö., & Ay, S. (2016). The effect of the duration of intravenous zolendronate medication on the success of non-surgical endodontic therapy: a retrospective study. BMC oral health, 16, 9. https://doi.org/10.1186/s12903-016-0163-6
DOI: https://doi.org/10.23857/pc.v9i12.8560
Enlaces de Referencia
- Por el momento, no existen enlaces de referencia
Polo del Conocimiento
Revista Científico-Académica Multidisciplinaria
ISSN: 2550-682X
Casa Editora del Polo
Manta - Ecuador
Dirección: Ciudadela El Palmar, II Etapa, Manta - Manabí - Ecuador.
Código Postal: 130801
Teléfonos: 056051775/0991871420
Email: polodelconocimientorevista@gmail.com / director@polodelconocimiento.com
URL: https://www.polodelconocimiento.com/
